DH10--Drug Decision Support Database Subscription
ID: 36C25926Q0059Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 19 (36C259)Greenwood Village, CO, 80111, USA

NAICS

Web Search Portals and All Other Information Services (519290)

PSC

IT AND TELECOM - PLATFORM AS A SERVICE: DATABASE, MAINFRAME, MIDDLEWARE (DH10)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/workspace/contract/opp/fc7ac44987304d0a8ea454e716f3f81e/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is soliciting quotes for a Drug Decision Support Database Subscription under RFQ # 36C25926Q0059, specifically set aside for small business concerns. The procurement requires a web-based database that can support up to 110 simultaneous users, providing extensive searchable capabilities for both US domestic and foreign medications, determining FDA approval status, and listing both approved and off-label indications with supporting studies. This subscription is crucial for the Foreign Medical Program, which processes pharmacy claims for US Veterans residing or traveling abroad, and the contract will be awarded as a firm-fixed price with a base year and four option years starting March 31, 2026. Interested vendors must submit their quotes, including technical capability, pricing, and an authorized distributor letter, by 12:00 PM MST on January 5, 2026, to Stephanie Cahill at Stephanie.Cahill@va.gov.

    Point(s) of Contact
    Stephanie CahillContract Specialist
    Email preferred
    Stephanie.Cahill@va.gov
    Files
    Title
    Posted
    36C25926Q0059.docx
    The Department of Veterans Affairs (VA) is seeking quotes for a Drug Decision Support Database Subscription (RFQ # 36C25926Q0059). This solicitation, set aside for small business concerns, requires a web-based database accessible to up to 110 simultaneous users, seven days a week, from 0600 to 2100 MST. The database must feature extensive searchable capabilities for US domestic and foreign medications, determine FDA approval status, cross-reference foreign medications with domestic counterparts, list approved and off-label indications with supporting studies, provide medication ingredients, and assess medication appropriateness for a Veteran's service-connected condition. The subscription also needs to offer web-based training. The contract will be a firm-fixed price with a base year and four option years, commencing March 31, 2026. Quotes, including technical capability, price, and an authorized distributor letter, are due by 12:00 PM MST, January 5, 2026, to Stephanie.Cahill@va.gov. Evaluation will prioritize technical capability, price, and the submission of an authorized distributor letter, with the government reserving the right to award to other than the lowest price if it is in the best interest of the Government.
    Lifecycle
    Title
    Type
    DH10--Drug Decision Support Database Subscription
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    DA01--State Prescription Drug Monitoring Program (PDMP) Integration Solution and Support Services - New Task Order (VA-26-00013141)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide integration solutions and sustainment support services for its State Prescription Drug Monitoring Program (PDMP) under task order VA-26-00013141. The procurement aims to maintain and enhance the existing PDMP solution, which connects VA healthcare providers to a national network of state-based PDMPs, facilitating the querying of controlled substance prescriptions. This initiative is crucial for improving patient safety and ensuring compliance with the MISSION Act Section 134. Interested vendors, particularly Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs) certified by the SBA's VetCert program, must submit their responses by January 5, 2026, at 10 AM EST, detailing their technical capabilities and experience, with a focus on the requirements outlined in the attached Request for Information documents. For further inquiries, contact Contract Specialist Edward Olivo-Cruz at Edward.Olivo-Cruz@va.gov or 848-377-5099.
    DA01--Reducing Inappropriate Polypharmacy at the Department of Veterans Affairs
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for a software solution aimed at reducing inappropriate polypharmacy among Veterans, as outlined in the presolicitation notice for Request for Information (RFI) number 36C10B25Q0550. The objective is to identify multi-drug interactions, optimize medication regimens, and support deprescribing through sophisticated, clinically-evidenced technology that adheres to VA's IT standards and ensures secure handling of patient data. This initiative is critical for improving medication management and clinical outcomes for Veterans, with a formal Request for Proposal (RFP) to be issued via Contracting Opportunities. Interested parties must ensure full registration in the System for Award Management (SAM.gov) and submit their responses by September 15, 2025, at 3 PM Eastern Time. For inquiries, contact Contract Specialist Elena Juliano at elena.juliano@va.gov or Contracting Officer John Vardouniotis at ioannis.vardouniotis@va.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for pharmaceutical agents to establish Blanket Purchase Agreements (BPAs) and an Additional Discount Program (ADP) as part of its Uniform Formulary for the Military Health System. This procurement aims to secure effective and cost-efficient pharmaceutical agents, including newly approved drugs for various therapeutic classes, which will be evaluated by the Pharmacy and Therapeutics (P&T) Committee for inclusion in the formulary. The selected agents will play a crucial role in providing essential medications to military personnel and their families, ensuring access to high-quality healthcare. Interested manufacturers must submit their quotes by January 5, 2026, with a pre-quotation teleconference scheduled for December 17, 2025; for further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Julia Trang at julia.n.trang.civ@health.mil.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    DA01--New Contract - Polypharmacy (VA-26-00018584)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a new contract titled "Reducing Inappropriate Polypharmacy" to address medication management issues within the VA healthcare system. The procurement aims to develop and implement software solutions that will enhance program management, pilot phases, and sustainment of services, with an estimated total award amount of $47 million over a base period of six months and four one-year option periods. This initiative is critical for improving patient care and reducing the risks associated with polypharmacy among veterans. Interested parties must respond to the solicitation by January 14, 2026, at 10 AM Eastern Time, and can contact Contract Specialist Elena Juliano at elena.juliano@va.gov or 848-377-5194 for further information.
    6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) for pharmaceutical agents to be included in the DoD Uniform Formulary (UF). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on oncological agents for myelofibrosis and antihemophilic agents, with evaluations based on clinical and cost-effectiveness. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025. For further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.